Logo image of QXO

QXO INC (QXO) Stock Fundamental Analysis

USA - NYSE:QXO - US82846H4056 - Common Stock

20.23 USD
+0.32 (+1.61%)
Last: 10/3/2025, 8:04:01 PM
20.33 USD
+0.1 (+0.49%)
After Hours: 10/3/2025, 8:04:01 PM
Fundamental Rating

3

Taking everything into account, QXO scores 3 out of 10 in our fundamental rating. QXO was compared to 49 industry peers in the Trading Companies & Distributors industry. While QXO seems to be doing ok healthwise, there are quite some concerns on its profitability. QXO shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

QXO had positive earnings in the past year.
In the past year QXO has reported a negative cash flow from operations.
QXO Yearly Net Income VS EBIT VS OCF VS FCFQXO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

QXO has a Return On Assets of -0.67%. This is in the lower half of the industry: QXO underperforms 67.35% of its industry peers.
With a Return On Equity value of -1.15%, QXO is not doing good in the industry: 67.35% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.67%
ROE -1.15%
ROIC N/A
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-5.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QXO Yearly ROA, ROE, ROICQXO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

QXO has a worse Gross Margin (21.49%) than 67.35% of its industry peers.
QXO's Gross Margin has been stable in the last couple of years.
QXO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5YN/A
QXO Yearly Profit, Operating, Gross MarginsQXO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

More info and screens

4

2. Health

2.1 Basic Checks

QXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
QXO has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, QXO has an improved debt to assets ratio.
QXO Yearly Shares OutstandingQXO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 100M 200M 300M 400M
QXO Yearly Total Debt VS Total AssetsQXO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.52, we must say that QXO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of QXO (1.52) is worse than 69.39% of its industry peers.
QXO has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
QXO's Debt to Equity ratio of 0.34 is fine compared to the rest of the industry. QXO outperforms 61.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 1.52
ROIC/WACCN/A
WACC9.84%
QXO Yearly LT Debt VS Equity VS FCFQXO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 3.00 indicates that QXO has no problem at all paying its short term obligations.
The Current ratio of QXO (3.00) is better than 79.59% of its industry peers.
QXO has a Quick Ratio of 2.15. This indicates that QXO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.15, QXO is in the better half of the industry, outperforming 77.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3
Quick Ratio 2.15
QXO Yearly Current Assets VS Current LiabilitesQXO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.22% over the past year.
The Revenue has grown by 3310.76% in the past year. This is a very strong growth!
Measured over the past years, QXO shows a quite strong growth in Revenue. The Revenue has been growing by 10.90% on average per year.
EPS 1Y (TTM)98.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.5%
Revenue 1Y (TTM)3310.76%
Revenue growth 3Y10.9%
Revenue growth 5YN/A
Sales Q2Q%13011.42%

3.2 Future

QXO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 94.13% yearly.
Based on estimates for the next years, QXO will show a very strong growth in Revenue. The Revenue will grow by 240.68% on average per year.
EPS Next Y692.5%
EPS Next 2Y222.73%
EPS Next 3Y145.72%
EPS Next 5Y94.13%
Revenue Next Year13052.4%
Revenue Next 2Y1331.05%
Revenue Next 3Y548.34%
Revenue Next 5Y240.68%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QXO Yearly Revenue VS EstimatesQXO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B
QXO Yearly EPS VS EstimatesQXO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 126.44 indicates a quite expensive valuation of QXO.
Compared to the rest of the industry, the Price/Earnings ratio of QXO indicates a slightly more expensive valuation: QXO is more expensive than 71.43% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.86. QXO is valued rather expensively when compared to this.
QXO is valuated quite expensively with a Price/Forward Earnings ratio of 39.67.
QXO's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. QXO is more expensive than 69.39% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, QXO is valued quite expensively.
Industry RankSector Rank
PE 126.44
Fwd PE 39.67
QXO Price Earnings VS Forward Price EarningsQXO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QXO Per share dataQXO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

QXO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
QXO's earnings are expected to grow with 145.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y222.73%
EPS Next 3Y145.72%

More info and screens

0

5. Dividend

5.1 Amount

QXO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QXO INC

NYSE:QXO (10/3/2025, 8:04:01 PM)

After market: 20.33 +0.1 (+0.49%)

20.23

+0.32 (+1.61%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners92.44%
Inst Owner Change-58.21%
Ins Owners0.05%
Ins Owner Change0.18%
Market Cap13.63B
Analysts87.5
Price Target34.4 (70.04%)
Short Float %6.12%
Short Ratio5.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.24
Dividend Growth(5Y)N/A
DP-67.51%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)101.11%
Min EPS beat(2)40.59%
Max EPS beat(2)161.62%
EPS beat(4)4
Avg EPS beat(4)118.62%
Min EPS beat(4)23.76%
Max EPS beat(4)248.52%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.08%
Min Revenue beat(2)0.71%
Max Revenue beat(2)11.45%
Revenue beat(4)3
Avg Revenue beat(4)2.36%
Min Revenue beat(4)-6.97%
Max Revenue beat(4)11.45%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.58%
PT rev (3m)-1.77%
EPS NQ rev (1m)-0.2%
EPS NQ rev (3m)-25.52%
EPS NY rev (1m)-1.43%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)-3.94%
Revenue NY rev (1m)3.26%
Revenue NY rev (3m)48.78%
Valuation
Industry RankSector Rank
PE 126.44
Fwd PE 39.67
P/S 7
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 17.61
EV/EBITDA N/A
EPS(TTM)0.16
EY0.79%
EPS(NY)0.51
Fwd EY2.52%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS2.89
BVpS14.72
TBVpS1.15
PEG (NY)0.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.67%
ROE -1.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.49%
FCFM N/A
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-5.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5YN/A
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.3%
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3
Quick Ratio 2.15
Altman-Z 1.52
F-Score3
WACC9.84%
ROIC/WACCN/A
Cap/Depr(3y)12.68%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.27%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.5%
EPS Next Y692.5%
EPS Next 2Y222.73%
EPS Next 3Y145.72%
EPS Next 5Y94.13%
Revenue 1Y (TTM)3310.76%
Revenue growth 3Y10.9%
Revenue growth 5YN/A
Sales Q2Q%13011.42%
Revenue Next Year13052.4%
Revenue Next 2Y1331.05%
Revenue Next 3Y548.34%
Revenue Next 5Y240.68%
EBIT growth 1Y-33288.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1074.56%
EBIT Next 3Y193.6%
EBIT Next 5Y113.63%
FCF growth 1Y18215.2%
FCF growth 3Y813.27%
FCF growth 5YN/A
OCF growth 1Y14439.7%
OCF growth 3Y621.5%
OCF growth 5YN/A